Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 50.37 USD | +2.03% |
|
-2.82% | -47.17% |
| 08-07 | Espiria Hållbar Framtid rose 2.5 percent in July - cut holdings in Bristol Myers Squibb, Merck and Novo Nordisk | FW |
| 08-05 | Wall Street warms to healthcare stocks as tech trade faces turbulence | RE |
| Market Cap | 73B 62.53B 58.51B 53.56B 101B 6,984B 102B 691B 270B 3,509B 274B 268B 11,605B | P/E 2026 * |
18.8x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 81.71B 70B 65.49B 59.95B 113B 7,818B 114B 774B 302B 3,928B 307B 300B 12,991B | EV / Sales 2026 * |
3.82x | EV / Sales 2027 * | 3.51x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Boston Scientific Corporation
| 1 day | +2.03% | ||
| 1 week | -2.82% | ||
| Current month | +7.79% | ||
| 1 month | +15.58% | ||
| 3 months | -12.82% | ||
| 6 months | -32.27% | ||
| Current year | -47.17% |
| 1 week | 49.01 |  | 52.56 |
| 1 month | 42.55 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 109.5 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% | ||
| 05/08/26 | Buy | Director | 2,100 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.03% | -2.82% | -52.56% | +0.04% | 73B | |
| +0.27% | +6.97% | +25.86% | +15.41% | 233B | |
| +1.36% | +8.10% | +3.33% | -14.13% | 154B | |
| +1.16% | -3.98% | -20.44% | +30.45% | 134B | |
| +0.98% | +2.26% | -16.22% | -12.85% | 52.24B | |
| -0.04% | -1.98% | +9.73% | +18.30% | 51.75B | |
| +1.73% | +7.05% | +30.72% | +33.47% | 44.91B | |
| +1.49% | -0.36% | +35.91% | +51.53% | 40.35B | |
| +1.03% | +1.53% | -0.53% | +8.45% | 33.8B | |
| +1.35% | +3.15% | -21.18% | +42.91% | 33.4B | |
| Average | +1.02% | +1.99% | -0.54% | +17.36% | 84.98B | |
| Weighted average by Cap. | +0.92% | +3.06% | +2.02% | +13.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.37B 18.3B 17.12B 15.68B 29.42B 2,044B 29.81B 202B 78.9B 1,027B 80.23B 78.48B 3,397B | 22.33B 19.13B 17.9B 16.38B 30.75B 2,136B 31.15B 211B 82.46B 1,073B 83.85B 82.02B 3,550B |
| Net income | 3.84B 3.29B 3.08B 2.82B 5.29B 367B 5.36B 36.35B 14.18B 185B 14.42B 14.1B 610B | 3.69B 3.16B 2.95B 2.7B 5.08B 353B 5.14B 34.91B 13.61B 177B 13.84B 13.54B 586B |
| Net Debt | 8.72B 7.47B 6.99B 6.4B 12B 834B 12.16B 82.55B 32.19B 419B 32.73B 32.02B 1,386B | 5.45B 4.67B 4.37B 4B 7.51B 522B 7.61B 51.63B 20.13B 262B 20.47B 20.03B 867B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | US$50.37 | +2.03% | 35,992,162 |
| 20/08/26 | US$49.37 | -5.08% | 20,390,548 |
| 19/08/26 | US$52.01 | +3.05% | 16,834,155 |
| 18/08/26 | US$50.47 | -1.87% | 11,724,272 |
| 17/08/26 | US$51.43 | -0.77% | 18,151,325 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
